Aspergillosis classification: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) |
m (Changes made per Mahshid's request) |
||
| (6 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Aspergillosis}} | {{Aspergillosis}} | ||
{{CMG}} {{AE}} {{YD}}; {{HL}}; {{SSK}} | |||
==Overview== | ==Overview== | ||
Apergillosis may be classified according to the clinical syndrome it causes into allergic bronchopulmonary aspergillosis, allergic ''Aspergillus'' sinusitis, aspergilloma, chronic pulmonary aspergillosis, invasive aspergillosis, or cutaneous aspergillosis. | Apergillosis may be classified according to the clinical syndrome it causes into allergic bronchopulmonary aspergillosis, allergic ''Aspergillus'' sinusitis, aspergilloma, chronic pulmonary aspergillosis, invasive aspergillosis, or cutaneous aspergillosis. | ||
| Line 12: | Line 14: | ||
*Cutaneous aspergillosis | *Cutaneous aspergillosis | ||
<br> | <br> | ||
The table below distinguishes between the different types of aspergillosis:<ref name=CDC> Definition of Aspergillosis - Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/fungal/diseases/aspergillosis/definition.html Accessed on Feb 8 2016</ref> | The table below distinguishes between the different types of aspergillosis:<ref name="CDC">Definition of Aspergillosis - Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/fungal/diseases/aspergillosis/definition.html Accessed on Feb 8 2016</ref> | ||
{| {{table}} | {| {{table}} cellpadding="4" cellspacing="0" style="border:#c9c9c9 1px solid; margin: 1em 1em 1em 0; border-collapse: collapse;" | ||
| align="center" style="background:#f0f0f0;"|'''Clinical Syndrome''' | | align="center" style="background:#f0f0f0;" |'''Clinical Syndrome''' | ||
| align="center" style="background:#f0f0f0;"|'''Characteristics''' | | align="center" style="background:#f0f0f0;" |'''Characteristics''' | ||
|- | |- | ||
| '''Allergic Bronchopulmonary Aspergillosis (ABPA)'''|| | | '''Allergic Bronchopulmonary Aspergillosis (ABPA)'''|| | ||
*Immune-modulated pulmonary disease due to hypersensitivity to ''A. fumigatus'' (not an infection) | *Immune-modulated pulmonary disease due to hypersensitivity to ''A. fumigatus'' (not an infection) | ||
*Clinical features include persistent | *Clinical features include persistent cough, wheezing, symptoms of asthma exacerbation or bronchiectasis | ||
*Common among patients with [[asthma]] | *Common among patients with [[asthma]] | ||
*Recurrent pulmonary infiltrates on chest imaging | *Recurrent pulmonary infiltrates on chest imaging | ||
*May result in development of [[bronchiectasis]], chronic pulmonary aspergillosis, or aspergilloma | *May result in development of [[bronchiectasis]], chronic pulmonary aspergillosis, or aspergilloma | ||
*Treatment with [[Antifungal drug|antifungal agents]], [[steroids]], and [[Asthma medical therapy|asthma control]]<ref name=Agarwal>{{cite journal| author=Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R et al.| title=Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. | journal=Clin Exp Allergy | year= 2013 | volume= 43 | issue= 8 | pages= 850-73 | pmid=23889240 | doi=10.1111/cea.12141 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23889240 }}</ref> | *Treatment with [[Antifungal drug|antifungal agents]], [[steroids]], and [[Asthma medical therapy|asthma control]]<ref name="Agarwal">{{cite journal| author=Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R et al.| title=Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. | journal=Clin Exp Allergy | year= 2013 | volume= 43 | issue= 8 | pages= 850-73 | pmid=23889240 | doi=10.1111/cea.12141 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23889240 }}</ref> | ||
|- | |- | ||
| '''Allergic ''Aspergillus'' Sinusitis / Rhinosinusitis'''|| | | '''Allergic ''Aspergillus'' Sinusitis / Rhinosinusitis'''|| | ||
*Immune-modulated sinus disease (not an infection) | *Immune-modulated sinus disease (not an infection) | ||
*Clinical features of recurrent or resistant [[sinusitis]], such as increased sinus drainage, [[stuffiness]], [[headache]], | *Clinical features of recurrent or resistant [[sinusitis]], such as increased sinus drainage, [[stuffiness]], [[headache]], facial tenderness, and eosinophilic secretions | ||
*Non-invasive | *Non-invasive | ||
*Common in healthy young adults | *Common in healthy young adults | ||
*Diagnosed using Bent and Kuhn diagnostic criteria (see criteria [[Aspergillosis diagnostic criteria|'''here''']]) | *Diagnosed using Bent and Kuhn diagnostic criteria (see criteria [[Aspergillosis diagnostic criteria|'''here''']]) | ||
*Unilateral, asymmetric involvement of sinues with bone erosions on imaging | *Unilateral, asymmetric involvement of sinues with bone erosions on imaging | ||
*Treamtent includes de-obstruction, nasal drainage, oral steroids, immunotherapy against allergens, and allergy control<ref name=glass>{{cite journal| author=Glass D, Amedee RG| title=Allergic fungal rhinosinusitis: a review. | journal=Ochsner J | year= 2011 | volume= 11 | issue= 3 | pages= 271-5 | pmid=21960761 | doi= | pmc=PMC3179194 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21960761 }} </ref> | *Treamtent includes de-obstruction, nasal drainage, oral steroids, immunotherapy against allergens, and allergy control<ref name="glass">{{cite journal| author=Glass D, Amedee RG| title=Allergic fungal rhinosinusitis: a review. | journal=Ochsner J | year= 2011 | volume= 11 | issue= 3 | pages= 271-5 | pmid=21960761 | doi= | pmc=PMC3179194 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21960761 }} </ref> | ||
|- | |- | ||
| '''Aspergilloma (Fungus Ball)'''|| | | '''Aspergilloma (Fungus Ball)'''|| | ||
*An ''Aspergillus'' mass | *An ''Aspergillus'' mass colonizes locally in either the lungs or the sinuses | ||
*May occur with chronic pulmonary aspergillosis | *May occur with chronic pulmonary aspergillosis | ||
*Clinical features vary from an asymptomatic course to fatal [[hemoptysis]] | *Clinical features vary from an asymptomatic course to fatal [[hemoptysis]] | ||
*Common among individuals with prior history of lung diseases, including [[tuberculosis]] | *Common among individuals with prior history of lung diseases, including [[tuberculosis]] | ||
*Chest CT in prone position shows movable fungus ball | *Chest CT in prone position shows movable fungus ball | ||
*Treatment includes surgical resection<ref name=lee>{{cite journal| author=Lee SH, Lee BJ, Jung DY, Kim JH, Sohn DS, Shin JW et al.| title=Clinical manifestations and treatment outcomes of pulmonary aspergilloma. | journal=Korean J Intern Med | year= 2004 | volume= 19 | issue= 1 | pages= 38-42 | pmid=15053042 | doi= | pmc=PMC4531547 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15053042 }} </ref> | *Treatment includes surgical resection<ref name="lee">{{cite journal| author=Lee SH, Lee BJ, Jung DY, Kim JH, Sohn DS, Shin JW et al.| title=Clinical manifestations and treatment outcomes of pulmonary aspergilloma. | journal=Korean J Intern Med | year= 2004 | volume= 19 | issue= 1 | pages= 38-42 | pmid=15053042 | doi= | pmc=PMC4531547 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15053042 }} </ref> | ||
|- | |- | ||
| '''Chronic Pulmonary Aspergillosis'''|| | | '''Chronic Pulmonary Aspergillosis'''|| | ||
*Invasion of ''Aspergillus'' in the | *Invasion of ''Aspergillus'' in the lungs for > 3 months | ||
*May occur with aspergillomas (single or multiple) | *May occur with aspergillomas (single or multiple) | ||
*Clinical features include [[weight loss]], [[Ccough|chronic | *Clinical features include [[weight loss]], [[Ccough|chronic productive cough]], [[dyspnea]], and [[hemoptysis]] | ||
*On Imaging, 1 of 3 patterns is characteristic: multiple cavities (chronic cavitary pulmonary aspergillosis - CCPA, in immunocompetent patients, chronic course), fibrosis (chronic fibrosing pulmonary aspergillosis - CFPA, in immunocompetent patient, chronic course, follows CCPA), or subacutely enlarging single cavity ( | *On Imaging, 1 of 3 patterns is characteristic: 1) multiple cavities (chronic cavitary pulmonary aspergillosis - CCPA, in immunocompetent patients, chronic course), 2) fibrosis (chronic fibrosing pulmonary aspergillosis - CFPA, in immunocompetent patient, chronic course, follows CCPA), or 3) subacutely enlarging single cavity (chronic necrotizing pulmonary aspergillosis - CNPA, subacute within weeks i.e. not chronic, in immunocompromised patients) | ||
*Treatment includes systemic | *Treatment includes systemic antifungal therapy with or without intracavitary [[Antifungal drug|antifungal agents]]<ref name="denning">{{cite journal| author=Denning DW, Riniotis K, Dobrashian R, Sambatakou H| title=Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. | journal=Clin Infect Dis | year= 2003 | volume= 37 Suppl 3 | issue= | pages= S265-80 | pmid=12975754 | doi=10.1086/376526 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12975754 }} </ref> | ||
|- | |- | ||
| '''Invasive Aspergillosis'''|| | | '''Invasive Aspergillosis'''|| | ||
| Line 57: | Line 59: | ||
*Classical triad of [[fever]], [[pleuritic chest pain]], and [[hemoptysis]] | *Classical triad of [[fever]], [[pleuritic chest pain]], and [[hemoptysis]] | ||
*Focal [[nodule]]s and [[infiltration]] common on imaging | *Focal [[nodule]]s and [[infiltration]] common on imaging | ||
*Treatment includes [[Antifungal drug|antifungal agents]]<ref name=nryn>{{cite journal| author=Naaraayan A, Kavian R, Lederman J, Basak P, Jesmajian S| title=Invasive pulmonary aspergillosis - case report and review of literature. | journal=J Community Hosp Intern Med Perspect | year= 2015 | volume= 5 | issue= 1 | pages= 26322 | pmid=25656673 | doi=10.3402/jchimp.v5.26322 | pmc=PMC4318821 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25656673 }} {{cite journal| author=Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW et al.| title=Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. | journal=N Engl J Med | year= 2002 | volume= 347 | issue= 6 | pages= 408-15 | pmid=12167683 | doi=10.1056/NEJMoa020191 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12167683 }} </ref> | *Treatment includes [[Antifungal drug|antifungal agents]]<ref name="nryn">{{cite journal| author=Naaraayan A, Kavian R, Lederman J, Basak P, Jesmajian S| title=Invasive pulmonary aspergillosis - case report and review of literature. | journal=J Community Hosp Intern Med Perspect | year= 2015 | volume= 5 | issue= 1 | pages= 26322 | pmid=25656673 | doi=10.3402/jchimp.v5.26322 | pmc=PMC4318821 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25656673 }} {{cite journal| author=Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW et al.| title=Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. | journal=N Engl J Med | year= 2002 | volume= 347 | issue= 6 | pages= 408-15 | pmid=12167683 | doi=10.1056/NEJMoa020191 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12167683 }} </ref> | ||
|- | |- | ||
| '''Cutaneous Aspergillosis'''|| | | '''Cutaneous Aspergillosis'''|| | ||
*Infection of the skin | *Infection of the skin | ||
*Invasion may be either primary through a skin lesion (e.g. [[Surgical wound|surgical]] or [[burn wound]] or at [[catheter site]]) or secondary to a distant organ to the skin | *Invasion may be either primary through a skin lesion (e.g. [[Surgical wound|surgical]] or [[burn wound]] or at [[catheter site]]) or secondary to a distant organ with subsequent dissemination to the skin | ||
*Common among immunocompromised individuals | *Common among immunocompromised individuals and neonates | ||
*Clinical features usually include [[fever]], change in lesion morphology. Lesions are | *Clinical features usually include [[fever]], change in lesion morphology. Lesions are commonly [[macule]]s, [[papule]]s, [[nodule]]s, or [[plaque]]s. Other lesions may also occur. | ||
*Diagnosis is by biopsy of the lesion, evaluation of other primary sources (e.g. CT scan for pulmonary | *Diagnosis is by biopsy of the lesion, evaluation of other primary sources (e.g. CT scan for pulmonary lesions) is necessary | ||
*Treatment includes [[Antifungal drug|antifungal agents]] with or without surgery<ref name=van>{{cite journal| author=van Burik JA, Colven R, Spach DH| title=Cutaneous aspergillosis. | journal=J Clin Microbiol | year= 1998 | volume= 36 | issue= 11 | pages= 3115-21 | pmid=9774549 | doi= | pmc=PMC105285 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9774549 }} </ref> | *Treatment includes [[Antifungal drug|antifungal agents]] with or without surgery<ref name="van">{{cite journal| author=van Burik JA, Colven R, Spach DH| title=Cutaneous aspergillosis. | journal=J Clin Microbiol | year= 1998 | volume= 36 | issue= 11 | pages= 3115-21 | pmid=9774549 | doi= | pmc=PMC105285 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9774549 }} </ref> | ||
|} | |} | ||
| Line 72: | Line 74: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Fungal diseases]] | [[Category:Fungal diseases]] | ||
Latest revision as of 17:01, 18 September 2017
|
Aspergillosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Aspergillosis classification On the Web |
|
American Roentgen Ray Society Images of Aspergillosis classification |
|
Risk calculators and risk factors for Aspergillosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Haytham Allaham, M.D. [2]; Serge Korjian M.D.
Overview
Apergillosis may be classified according to the clinical syndrome it causes into allergic bronchopulmonary aspergillosis, allergic Aspergillus sinusitis, aspergilloma, chronic pulmonary aspergillosis, invasive aspergillosis, or cutaneous aspergillosis.
Classification
Apergillosis may be classified according to the clinical syndrome it causes into the following:
- Allergic bronchopulmonary aspergillosis
- Allergic Aspergillus sinusitis
- Aspergilloma
- Chronic pulmonary aspergillosis
- Invasive aspergillosis
- Cutaneous aspergillosis
The table below distinguishes between the different types of aspergillosis:[1]
| Clinical Syndrome | Characteristics |
| Allergic Bronchopulmonary Aspergillosis (ABPA) |
|
| Allergic Aspergillus Sinusitis / Rhinosinusitis |
|
| Aspergilloma (Fungus Ball) |
|
| Chronic Pulmonary Aspergillosis |
|
| Invasive Aspergillosis |
|
| Cutaneous Aspergillosis |
|
References
- ↑ Definition of Aspergillosis - Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/fungal/diseases/aspergillosis/definition.html Accessed on Feb 8 2016
- ↑ Agarwal R, Chakrabarti A, Shah A, Gupta D, Meis JF, Guleria R; et al. (2013). "Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria". Clin Exp Allergy. 43 (8): 850–73. doi:10.1111/cea.12141. PMID 23889240.
- ↑ Glass D, Amedee RG (2011). "Allergic fungal rhinosinusitis: a review". Ochsner J. 11 (3): 271–5. PMC 3179194. PMID 21960761.
- ↑ Lee SH, Lee BJ, Jung DY, Kim JH, Sohn DS, Shin JW; et al. (2004). "Clinical manifestations and treatment outcomes of pulmonary aspergilloma". Korean J Intern Med. 19 (1): 38–42. PMC 4531547. PMID 15053042.
- ↑ Denning DW, Riniotis K, Dobrashian R, Sambatakou H (2003). "Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review". Clin Infect Dis. 37 Suppl 3: S265–80. doi:10.1086/376526. PMID 12975754.
- ↑ Naaraayan A, Kavian R, Lederman J, Basak P, Jesmajian S (2015). "Invasive pulmonary aspergillosis - case report and review of literature". J Community Hosp Intern Med Perspect. 5 (1): 26322. doi:10.3402/jchimp.v5.26322. PMC 4318821. PMID 25656673. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW; et al. (2002). "Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis". N Engl J Med. 347 (6): 408–15. doi:10.1056/NEJMoa020191. PMID 12167683.
- ↑ van Burik JA, Colven R, Spach DH (1998). "Cutaneous aspergillosis". J Clin Microbiol. 36 (11): 3115–21. PMC 105285. PMID 9774549.